Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: i-node who wrote (211226)	11/9/2004 1:22:10 PM
From: Alighieri	Read Replies (2) \| Respond to of 1570343

The bill doesn't provide for the FED to BUY anything. Thank you. I have made five posts with the same central point. Geeez.. It provides particular reimbursement rates for particular drugs. It does not. It stipulates that private regional service providers (most logically HMOs) provide the service to seniors. That excludes the fed goverment except from the process, other than paying the bills. Everybody makes money. Probably lots of money. Little wonder big drug and HMO companies lobbyied brutally for the provisions of the bill that forbid VPAs. Even though one would think that volumes now become concentrated and somewhat guaranteed to certain suppliers. If you reimport from Canada a drug which is sold at a higher price in the United States, the savings are simply cost-shifted to those in the United States who are not on Medicare,... ...who alternatively could/might buy some drugs from Canada or other geos, hence market forces begin to govern cost of drugs, which could have a levelling effect on pricing in different regions/geographies...etc... the market does not have the fit the partisan interpretation and outcome you conveniently assign to it. To have great drugs, the capital markets require a certain return on investment. If they aren't getting that return, the drugs don't happen. What other basic concepts of economics would you like to share with the thread. Man...you must be an insufferable hardass. Selling drugs for less money in other nations is simply the global marketplace at work. While it seems unfair to us, the amount which can be charged for a drug in Africa... If you use an extreme examples to make your case, I can see how you can deceive yourself into believing garbage...now apply the same concept relative to an equivalent economy like Canada or other industrialized nations...the price of drugs across geos is influenced by many other factors, not the least of which is generics, the effect of IP protection and medical trends. What you argue for and the bill does is little more than anticompetitive practices with the aid of a partisan, heavily lobbyied fed goverment. RD shortfalls to close the business case can and should be handled on their merits, not through price fixing. Al